Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation

被引:30
作者
Binkley, Michael S. [1 ]
Hiniker, Susan M. [1 ]
Chaudhuri, Aadel [1 ]
Maxim, Peter G. [1 ,2 ]
Diehn, Maximilian [1 ,2 ,3 ]
Loo, Billy W., Jr. [1 ,2 ]
Shultz, David Benjamin [4 ,5 ]
机构
[1] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA
[4] Princess Margaret Canc Ctr, Dept Radiat Oncol, Toronto, ON, Canada
[5] Univ Toronto, Dept Radiat Oncol, Ofc 5-809,610 Univ Ave, Toronto, ON M5G 2M9, Canada
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 94卷 / 04期
关键词
CELL LUNG-CANCER; STEREOTACTIC ABLATIVE RADIOTHERAPY; PROTON-BEAM THERAPY; RADIATION-THERAPY; TUMORS;
D O I
10.1016/j.ijrobp.2015.12.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: We determined cumulative dose to critical structures, rates of toxicity, and outcomes following thoracic reirradiation. Methods and Materials: We retrospectively reviewed our institutional database for patients treated between 2008 and 2014, who received thoracic reirradiation with overlap of 25% prescribed isodose lines. Patients received courses of hyperfractionated (n=5), hypofractionated (n=5), conventionally fractionated (n=21), or stereotactic ablative radiation therapy (n=51). Doses to critical structures were converted to biologically effective dose, expressed as 2 Gy per fraction equivalent dose (EQD2; alpha/beta = 2 for spinal cord; alpha/beta = 3 for other critical structures). Results: We identified 82 courses (44 for retreatment) in 38 patients reirradiated at a median 16 months (range: 1-71 months) following initial RT. Median follow-up was 17 months (range: 3-57 months). Twelve-and 24-month overall survival rates were 79.6% and 57.3%, respectively. Eighteen patients received reirradiation for locoregionally recurrent non-small cell lung cancer with 12-month rates of local failure and regional recurrence and distant metastases rates of 13.5%, 8.1%, and 15.6%, respectively. Critical structures receiving >= 75 Gy EQD2 included spinal cord (1 cm(3); n=1), esophagus (1 cm(3); n=10), trachea (1 cm(3); n=11), heart (1 cm(3); n=9), aorta (1 cm(3); n=16), superior vena cava (1 cm(3); n=12), brachial plexus (0.2 cm(3); n=2), vagus nerve (0.2 cm(3); n=7), sympathetic trunk (0.2 cm(3); n=4), chest wall (30 cm(3); n=12), and proximal bronchial tree (1 cm(3); n=17). Cumulative dose-volume (D cm(3)) toxicity following reirradiation data included esophagitis grade >= 2 (n=3, D1 cm(3) range: 41.0-100.6 Gy), chest wall grade >= 2 (n=4; D30 cm(3) range: 35.0-117.2 Gy), lung grade 2 (n=7; V20(combined-lung) range: 4.7%-21.7%), vocal cord paralysis (n=2; vagus nerve D0.2 cm(3) range: 207.5-302.2 Gy), brachial plexopathy (n=1; D0.2 cm(3) = 242.5 Gy), and Horner's syndrome (n=1; sympathetic trunk D0.2 cm(3) = 130.8 Gy). No grade >= 4 toxicity was observed. Conclusions: Overlapping courses of reirradiation can be safely delivered with acceptable toxicity. Some toxicities occurred acutely at doses considered safe for a single course of therapy (esophagus). We observed rib fracture, brachial plexopathy, and Horner's syndrome for patients receiving high cumulative doses to corresponding critical structures. (c) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:808 / 815
页数:8
相关论文
共 19 条
[1]  
Berman AT, 2013, J CLIN ONCOL S
[2]   High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer [J].
De Ruysscher, Dirk ;
Faivre-Finn, Corinne ;
Le Pechoux, Cecile ;
Peeters, Stephanie ;
Belderbos, Jose .
LANCET ONCOLOGY, 2014, 15 (13) :E620-E624
[3]   Brachial Plexopathy in Apical Non-Small Cell Lung Cancer Treated With Definitive Radiation: Dosimetric Analysis and Clinical Implications [J].
Eblan, Michael J. ;
Corradetti, Michael N. ;
Lukens, J. Nicholas ;
Xanthopoulos, Eric ;
Mitra, Nandita ;
Christodouleas, John P. ;
Grover, Surbhi ;
Fernandes, Annemarie T. ;
Langer, Corey J. ;
Evans, Tracey L. ;
Stevenson, James ;
Rengan, Ramesh ;
Apisarnthanarax, Smith .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (01) :175-181
[4]   Non-Small Cell Lung Cancer, Version 1.2015 [J].
Ettinger, David S. ;
Wood, Douglas E. ;
Akerley, Wallace ;
Bazhenova, Lyudmila A. ;
Borghaei, Hossein ;
Camidge, David Ross ;
Cheney, Richard T. ;
Chirieac, Lucian R. ;
D'Amico, Thomas A. ;
Demmy, Todd L. ;
Dilling, Thomas J. ;
Govindan, Ramaswamy ;
Grannis, Frederic W., Jr. ;
Horn, Leora ;
Jahan, Thierry M. ;
Komaki, Ritsuko ;
Kris, Mark G. ;
Krug, Lee M. ;
Lackner, Rudy P. ;
Lanuti, Michael ;
Lilenbaum, Rogerio ;
Lin, Jules ;
Loo, Billy W., Jr. ;
Martins, Renato ;
Otterson, Gregory A. ;
Patel, Jyoti D. ;
Pisters, Katherine M. ;
Reckamp, Karen ;
Riely, Gregory J. ;
Rohren, Eric ;
Schild, Steven ;
Shapiro, Theresa A. ;
Swanson, Scott J. ;
Tauer, Kurt ;
Yang, Stephen C. ;
Gregory, Kristina ;
Hughes, Miranda .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (12) :1738-1761
[5]   Aortic dose constraints when reirradiating thoracic tumors [J].
Evans, Jaden D. ;
Gomez, Daniel R. ;
Amini, Arya ;
Rebueno, Neal ;
Allen, Pamela K. ;
Martel, Mary K. ;
Rineer, Justin M. ;
Ang, Kie Kian ;
McAvoy, Sarah ;
Cox, James D. ;
Komaki, Ritsuko ;
Welsh, James W. .
RADIOTHERAPY AND ONCOLOGY, 2013, 106 (03) :327-332
[6]   Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapy [J].
Garg, Shalini ;
Gielda, Benjamin T. ;
Kiel, Krystyna ;
Turian, Julius V. ;
Fidler, Mary Jo ;
Batus, Marta ;
Bonomi, Philip ;
Sher, David J. .
PRACTICAL RADIATION ONCOLOGY, 2014, 4 (05) :342-348
[7]   High-dose, conventionally fractionated thoracic reirradiation for lung tumors [J].
Griffioen, Gwendolyn H. M. J. ;
Dahele, Max ;
de Haan, Patricia F. ;
van de Ven, Peter M. ;
Slotman, Ben J. ;
Senan, Suresh .
LUNG CANCER, 2014, 83 (03) :356-362
[8]   Salvage Stereotactic Body Radiation Therapy (SBRT) for Local Failure After Primary Lung SBRT [J].
Hearn, Jason W. D. ;
Videtic, Gregory M. M. ;
Djemil, Toufik ;
Stephans, Kevin L. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (02) :402-406
[9]   STEREOTACTIC BODY RADIATION THERAPY FOR PATIENTS WITH LUNG CANCER PREVIOUSLY TREATED WITH THORACIC RADIATION [J].
Kelly, Patrick ;
Balter, Peter A. ;
Rebueno, Neal ;
Sharp, Hadley J. ;
Liao, Zhongxing ;
Komaki, Ritsuko ;
Chang, Joe Y. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (05) :1387-1393
[10]   Predicting Radiation Pneumonitis After Stereotactic Ablative Radiation Therapy in Patients Previously Treated With Conventional Thoracic Radiation Therapy [J].
Liu, Hui ;
Zhang, Xu ;
Vinogradskiy, Yevgeniy Y. ;
Swisher, Stephen G. ;
Komaki, Ritsuko ;
Chang, Joe Y. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (04) :1017-1023